NCT07484022 2026-04-07Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerGenerate BiomedicinesPhase 1 Recruiting37 enrolled
NCT00369564 2021-08-11Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With CancerUniversity of South FloridaPhase 3 Completed250 enrolled 10 charts
NCT00365768 2016-09-09Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsColumbia UniversityPhase 2 Completed56 enrolled 5 charts
NCT00751205 2014-10-28Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)BayerPhase 2 Completed150 enrolled